Animal models in pharmacology and toxicology

Handbook of Laboratory Animal Science: Animal Models, Second Edition

Volumn 2, Issue , 2002, Pages 11-40

  Meyer, Otto ^a   Svendsen, Ove ^b  

^a DANISH VETERINARY AND FOOD ADMINISTRATION   (Denmark)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84969537930     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (46)

1. Larsen, M.Ø., The Use of the Göttingen Minipig in Diabetes Research. Development and Characterization of a Novel Non-Rodent Animal Model of Type 2 Diabetes by Means of Beta-Cell Injury and High Fat Feeding, Ph.D. thesis, Royal Veterinary and Agricultural University, Copenhagen, Denmark, 2001.
2. Claassen, V., Neglected factors in pharmacology and neuroscience research. Biopharmaceutics, animal characteristics maintenance, testing conditions, in Techniques in the Behavioral and Neural Sciences, Huston, J.P., Ed., Elsevier, Amsterdam, 1994, p. 486.
3. Svendsen, O. and Hansen, A.K., Biological variation, reproducibility and predictability of in vivo drug testing, Scand. J. Lab. Anim. Sci., 25, 86, 1998.
4. Zak, O. and Sande, M.A., Eds., Handbook of Animal Models of Infection. Experimental Models in Antimicrobial Chemotherapy, Academic Press, London, 1999, p. 1136.
5. Frimodt-Møller, N., Knudsen, J.D., and Espersen, F., The mouse peritonitis/sepsis model, in Handbook of Animal Models of Infection. Experimental Models in Antimicrobial Chemotherapy, Academic Press, London, 1999, p. 127.
6. Alder, J.D., Hamster model of syphilis, in Handbook of Animal Models of Infection. Experimental Models in Antimicrobial Chemotherapy, Academic Press, London, 1999, p. 285.
7. Orme, I.M., Murine models of tuberculosis, in Handbook of Animal Models of Infection. Experimental Models in Antimicrobial Chemotherapy, Academic Press, London, 1999, p. 315.
8. Kernacki, K.A., Hobden, J.A., and Hazlett, L.D., Murine model of bacterial keratitis, in Handbook of Animal Models of Infection. Experimental Models in Antimicrobial Chemotherapy, Academic Press, London, 1999, p. 361.
9. Hopkins, W.J., Mouse model of ascending urinary tract infection, in Handbook of Animal Models of Infection. Experimental Models in Antimicrobial Chemotherapy, Academic Press, London, 1999, p. 435.
10. Matsumoto, T., Rat bladder infection model, in Handbook of Animal Models of Infection. Experimental Models in Antimicrobial Chemotherapy, Academic Press, London, 1999, p. 447.
11. Findon, G., Subclinical pyelonephritis in the rat, in Handbook of Animal Models of Infection. Experimental Models in Antimicrobial Chemotherapy, Academic Press, London, 1999, p. 463.
12. Bremell, T., Experimental models of infectious arthritis, in Handbook of Animal Models of Infection. Experimental Models in Antimicrobial Chemotherapy, Academic Press, London, 1999, p. 539.
13. Lefort, A. and Fantin, B., Rabbit models of bacterial endocarditis, in Handbook of Animal Models of Infection. Experimental Models in Antimicrobial Chemotherapy, Academic Press, London, 1999, p. 611.
14. Croft, S.L. and Yardley, V., Animal models of visceral Leishmaniasis, in Handbook of Animal Models of Infection. Experimental Models in Antimicrobial Chemotherapy, Academic Press, London, 1999, p. 783.
15. Romig, T. and Bilger, B., Animal models of Echinococcosis, in Handbook of Animal Models of Infection. Experimental Models in Antimicrobial Chemotherapy, Academic Press, London, 1999, p. 873.
16. Ellenbroek, B.A. and Cools, A.R., Animal models for schizophrenia: an introduction, in Atypical Antipsychotics, Ellenbroek, B.A. and Cools, A.R., Eds., Birkenhäuser Verlag, Basel, Switzerland, 2000, p. 35.
17. Arnt, J., Screening models for antipsychotic drugs, in Atypical Antipsychotics, Ellenbroek, B.A. and Cools, A.R., Eds., Birkenhäuser Verlag, Basel, Switzerland, 2000, p. 99.
18. Ellenbroek, B.A., Sams-Dodd, F., and Cools, A.R., Simulation models for schizophrenia, in Atypical Antipsychotics, Ellenbroek, B.A. and Cools, A.R., Eds., Birkenhäuser Verlag, Basel, Switzerland, 2000, p. 121.
19. Tamura, A., Kawai, K., and Takagi, K., Animal models used in cerebral ischemia and stroke research, in Clinical Pharmacology of Cerebral Ischemia, Horst, G.J.T and Korf, J., Eds., Humana Press, Totowa, NJ, 1999, p. 265.
20. Tolwani, R.J., Jakowec, M.W., Petzinger, G.M., Green, S., and Waggie, J., Experimental models in Parkinson’s disease: insight from many models, Lab. Anim. Sci., 49, 363, 1991.
21. McNeill, J.H., Ed., Experimental Models of Diabetes, CRC Press, Boca Raton, FL, 1999.
22. Rodrigues, B., Poucheret, P., Battell, M.L., and McNeill, J.H., Streptozotocin-induced diabetes: induction, mechanism(s), and dose dependency, in Experimental Models of Diabetes, McNeill, J.H., Ed., CRC Press, Boca Raton, FL, 1999, p. 3.
23. Donaldson, L.F., Seckl, J.R., and McQueen, D.S., A discrete adjuvant-induced monoarthritis in the rat - effects of adjuvant dose, J. Neurosci. Methods, 49, 5, 1993.
24. Mapp, P.I., Walsh, D.A., Garret, N.E., Kidd, B.L., Cruwys, S.C., Polak, J.M., and Blake, D.R, Effect of three animal models of inflammation on nerve fibres in the synovium, Ann. Rheum. Dis., 53, 240, 1994.
25. Schaible, H.-G. and Grubb, B.D., Afferent and spinal mechanisms of joint pain, Pain, 55, 5, 1993.
26. McQueen, D.S., Inflammatory pain and the joint, in Pain and Neurogenic Inflammation, Brain, S.D. and Moore, P.K., Eds., Birkhäuser Verlag, Berlin, 1999, p. 137.
27. Billingham, M.E.J., Adjuvant arthritis: the first model, in Mechanisms and Models in Rheumatoid Arthritis, Henderson, B., Edwards, J.C.W., and Pettipher, E.R., Eds., Academic Press, New York, 1995, p. 389.
28. Tjølsen, A. and Hole, K., Animal models of analgesia, in The Pharmacology of Pain, Dickenson, A. and Besson, J.-M., Eds., Springer-Verlag, Berlin, 1997, p. 1.
29. Rønn, A., Nørgaard, K.M., Lykkegaard, K., and Svendsen, O., Effects of pre-or postoperative morphine and of preoperative ketamine in experimental surgery in rats, evaluated by pain scoring and c-fos expression, Scand. J. Lab. Anim. Sci., 27, 223, 2000.
30. Svendsen, O. and Lykkegaard, K., Neuronal c-fos immunoreactivity as a quantitative measure of stress and pain, Acta Agric. Scand., Sect. A, Animal Sci., (Suppl. 30), 131, 2001.
31. Brennan, T.J., Vandermeulen, E.P., and Gebhart, G.F., Characterization of a rat model of incisional pain, Pain, 64, 493, 1996.
32. Brennan, T.J., Postoperative models of nociception, ILAR J., 40, 129-136, 1999.
33. Lascelles, B.D.X., Waterman, A.E., Cripps, P.J., Livingston, A., and Henderson, G., Central sensitization as a result of surgical pain: investigation of the pre-emptive value of pethidine for ovariohysterectomy in the rat, Pain, 62, 201, 1995.
34. Slingsby, L.S. and Waterman-Pearson, A.E., The post-operative analgesic effects of ketamine after canine ovariohysterectomy - a comparison between pre-and post-operative administration, Res. Vet. Sci., 69, 147, 2000.
35. Agersø, H., Pharmacokinetics and Tissue Penetration of Amoxycillin in Actinobacillus pleuropneumoniae and Salmonella typhimurium Infected Pigs, Ph.D. thesis, Royal Veterinary and Agricultural University, Copenhagen, Denmark, 1996.
36. Lauritsen, B., Biochemical Markers as Indicators of the Efficacy of Antibacterial Treatment of Actinobacillus pleuropneumoniae Infection in Pigs, Ph.D. thesis, Royal Veterinary and Agricultural University, Copenhagen, Denmark, 2001.
37. Lindecrona, R.H., The Pharmacodynamic Effect of Amoxicillin and Danofloxacin Against Actinobacillus pleuropneumoniae and Salmonella Typhimurium in an In Vitro Pharmacodynamic Model, Ph.D. thesis, Royal Veterinary and Agricultural University, Copenhagen, Denmark, 1998.
38. Petersen, M.B., Pharmacodynamic and Pharmacokinetic Parameters of Benzimidalzoles in the Pig Using Oesophagostomum Dentatum as Model Parasite, Ph.D. thesis, Royal Veterinary and Agricultural University, Copenhagen, Denmark, 1998.
39. U.S. Environmental Protection Agency, Principles of neurotoxicity risk assessment (final report), Fed. Reg., 59, 42360, 1994.
40. Brown, N.A. and Fabro, S., The value of animal teratogenicity testing for predicting human risk, Clin. Obstet. Gynaecol., 26, 467, 1983.
41. Draize, J.H., Woodward, G., and Calvery, H.O., Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes, J. Pharmacol. Exp. Ther., 82, 377, 1944.
42. Palmer, A.K., Regulatory requirements for reproductive toxicity: theory and practice, in Developmental Toxicology, Kimmel, C.A. and Buelke-Sam, J., Eds., Raven Press, New York, 1981, p. 259.
43. Mylchrest, E., Sar, M., Catley, R.C., and Foster, P.M.D., Disruption of androgen-related reproductive development by di(n-butyl)phthalate during late gestation in rats is different from flutamide, Toxicol. Appl. Pharmacol., 156, 81, 1999.
44. U.S. Environmental Protection Agency, Proposed guideline for neurotoxicity risk assessment (final report), Fed. Reg., 60, 52032, 1995.
45. Organisation for Economic Co-Operation and Development [OECD], OECD Test Guidelines for the Testing of Chemicals. Proposal for New Test Guideline 426: Developmental Neurotoxicity Study. Environmental Health and Safety Division, draft document, Paris, October 1999.
46. Chernoff, N. and Kavlock, R.J., An in vivo teratology screen utilizing pregnant mice, J. Toxicol. Environ. Health., 10, 541, 1982.